Preclinical and Clinical Studies on the Use of Extracellular Vesicles Derived from Mesenchymal Stem Cells in the Treatment of Chronic Wounds
Molecular Pharmaceutics · 03.06.2024 · 21 (6) · 2637-2658
DOI: 10.1021/acs.molpharmaceut.3c01121 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 10.05.2024. Verfasst von Soheila Rezaei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan 3514799422, Iran. Hauptthemen laut MEDLINE: Extracellular Vesicles, Mesenchymal Stem Cells, Wound Healing. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 127 Literaturangaben. Gefördert von: Semnan University of Medical Sciences and Health Services.
Themen: Wundversorgung
Abstract (Originalsprache)
To date, the widespread implementation of therapeutic strategies for the treatment of chronic wounds, including debridement, infection control, and the use of grafts and various dressings, has been time-consuming and accompanied by many challenges, with definite success not yet achieved. Extensive studies on mesenchymal stem cells (MSCs) have led to suggestions for their use in treating various diseases. Given the existing barriers to utilizing such cells and numerous pieces of evidence indicating the crucial role of the paracrine signaling system in treatments involving MSCs, extracellular vesicles (EVs) derived from these cells have garnered significant attention in treating chronic wounds in recent years. This review begins with a general overview of current methods for chronic wound treatment, followed by an exploration of EV structure, biogenesis, extraction methods, and characterization. Subsequently, utilizing databases such as Google Scholar, PubMed, and ScienceDirect, we have explored the latest findings regarding the role of EVs in the healing of chronic wounds, particularly diabetic and burn wounds. In this context, the role and mode of action of these nanoparticles in healing chronic wounds through mechanisms such as oxygen level elevation, oxidative stress damage reduction, angiogenesis promotion, macrophage polarization assistance, etc., as well as the use of EVs as carriers for engineered nucleic acids, have been investigated. The upcoming challenges in translating EV-based treatments for healing chronic wounds, along with possible approaches to address these challenges, are discussed. Additionally, clinical trial studies in this field are also covered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan 3514799422, Iran.
- Department of Medical Biotechnology, Faculty of Medicine, Semnan University of Medical Sciences, Semnan 3514799422Iran.
- Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran 1416753955, Iran.
- Skin Repair Research Center, Jordan Dermatology and Hair Transplantation Center, Shahid Beheshti University of Medical Sciences, Tehran 1516745811, Iran.
- Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran 16635148, Iran.
ORCID-Profile: Davood Nasrabadi
Förderung
- Semnan University of Medical Sciences and Health Services
Zitieren
APA
Rezaei, S., Nilforoushzadeh, M. A., Amirkhani, M. A., Moghadasali, R., Taghiabadi, E., & Nasrabadi, D. (2024). Preclinical and Clinical Studies on the Use of Extracellular Vesicles Derived from Mesenchymal Stem Cells in the Treatment of Chronic Wounds. Molecular Pharmaceutics, 21(6), 2637-2658. https://doi.org/10.1021/acs.molpharmaceut.3c01121
Vancouver
Rezaei S, Nilforoushzadeh MA, Amirkhani MA, Moghadasali R, Taghiabadi E, Nasrabadi D. Preclinical and Clinical Studies on the Use of Extracellular Vesicles Derived from Mesenchymal Stem Cells in the Treatment of Chronic Wounds. Molecular Pharmaceutics. 2024;21(6):2637-2658. doi:10.1021/acs.molpharmaceut.3c01121
BibTeX
@article{Rezaei2024,
author = {Rezaei, Soheila and Nilforoushzadeh, Mohammad Ali and Amirkhani, Mohammad Amir and Moghadasali, Reza and Taghiabadi, Ehsan and Nasrabadi, Davood},
title = {Preclinical and Clinical Studies on the Use of Extracellular Vesicles Derived from Mesenchymal Stem Cells in the Treatment of Chronic Wounds},
journal = {Molecular Pharmaceutics},
year = {2024},
volume = {21},
number = {6},
pages = {2637--2658},
doi = {10.1021/acs.molpharmaceut.3c01121}
}
EUVIMED